Facilitating rapid precision oncology in anaplastic thyroid cancer: Clinical implications of next generation sequencing (NGS) mutation testing and impact on survival.

被引：3
|
作者：
Wang, Jennifer Rui
Cote, Gilbert J.
Zafereo, Mark
Iyer, Priyanka C.
Dadu, Ramona
Busaidy, Naifa Lamki
Gross, Neil D.
Sturgis, Erich M.
Ferrarotto, Renata
Lu, Charles
Gunn, Gary Brandon
Myers, Jeffrey
Lai, Stephen Yenzen
Williams, Michelle D.
Cabanillas, Maria E.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Div Canc Med, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.6023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6023
引用
收藏
页数：2
相关论文
共 29 条
  • [21] Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement
    Colomer, Ramon
    Miranda, Jesus
    Romero-Laorden, Nuria
    Hornedo, Javier
    Gonzalez-Cortijo, Lucia
    Mouron, Silvana
    Bueno, Maria J.
    Mondejar, Rebeca
    Quintela-Fandino, Miguel
    ECLINICALMEDICINE, 2023, 60
  • [22] Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
    Cheng, Donavan T.
    Mitchell, Talia N.
    Zehir, Ahmet
    Shah, Ronak H.
    Benayed, Ryma
    Syed, Aijazuddin
    Chandramohan, Raghu
    Liu, Zhen Yu
    Won, Helen H.
    Scott, Sasinya N.
    Brannon, A. Rose
    O'Reilly, Catherine
    Sadowska, Justyna
    Casanova, Jacklyn
    Yannes, Angela
    Hechtman, Jaclyn F.
    Yao, Jinjuan
    Song, Wei
    Ross, Dara S.
    Oultache, Alifya
    Dogan, Snjezana
    Borsu, Laetitia
    Hameed, Meera
    Nafa, Khedoudja
    Arcila, Maria E.
    Ladanyi, Marc
    Berger, Michael F.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (03): : 251 - 264
  • [23] Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital
    Simarro, Javier
    Perez-Simo, Gema
    Mancheno, Nuria
    Ansotegui, Emilio
    Munoz-Nunez, Carlos Francisco
    Gomez-Codina, Jose
    Juan, Oscar
    Palanca, Sarai
    CANCERS, 2023, 15 (06)
  • [24] Economic impact of next-generation sequencing (NGS) versus single-gene testing modalities to detect genomic alterations (GAs) in metastatic non-small cell lung cancer (mNSCLC) in Asia
    Loong, H.
    Wong, C. K. H.
    Leung, L. K. S.
    Chan, C. P. K.
    Chang, A.
    Zhou, Z-Y.
    Tang, W.
    Gibbs, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S1394 - S1395
  • [25] Next Generation Sequencing (NGS) Based Minimal Residual Disease (MRD) Testing Is Highly Predictive of Overall and Progression Free Survival in the Total Therapy Trials and Shows Different Prognostic Implications in High Vs Standard Risk Multiple Myeloma
    Schinke, Carolina
    Deshpande, Shayu
    Wang, Hongwei
    Carlton, Victoria
    Kong, Katherine A.
    Moorhead, Martin
    Willis, Tom
    Patel, Purvi
    Thanendrarajan, Sharmilan
    Mohan, Meera
    Mathur, Pankaj
    Susanibar, Sandra
    Hoque, Shadiqul
    Radhakrishnan, Muthukumar
    Tytarenko, Ruslana
    Stephens, Owen W.
    Rasche, Leo
    van Rhee, Frits
    Zangari, Maurizio
    Petty, Nathan
    Alapat, Daisy V.
    Johnson, Sarah K.
    Epstein, Joshua
    Barlogie, Bart
    Davies, Faith E.
    Hoering, Antje
    Weinhold, Niels
    Morgan, Gareth J.
    BLOOD, 2016, 128 (22)
  • [26] Is Next-Generation Sequencing (NGS) Ready for Routine Clinical Practice in Advanced Well Differentiated Pancreatic Neuroendocrine Tumors (WD panNETs): Results of a Prospective Study Utilizing MSK-IMPACT (Memorial Sloan Kettering Integrated Mutation Profiling of Actionable Cancer Targets)
    Raj, Nitya
    Soumerai, Tara
    Valentino, Emily
    Reidy-Lagunes, Diane
    PANCREAS, 2016, 45 (03) : 468 - 469
  • [27] Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing
    Triner, D.
    Graf, R. P.
    Madison, R. W.
    Gjoerup, O.
    Tukachinsky, H.
    Ross, J. S.
    Quintanilha, J. C. F.
    Li, G.
    Cheng, H. H.
    Pritchard, C. C.
    Zurita, A. J.
    Qin, Q.
    Zhang, T.
    Agarwal, N.
    Reichert, Z. R.
    Mateo, J.
    Cieslik, M.
    Morgan, T. M.
    ESMO OPEN, 2024, 9 (09)
  • [28] Uncovering the differential impact of ESR1 and PIK3CA codon variants on the clinical phenotype of metastatic breast cancer (MBC) through circulating tumor DNA (ctDNA) next-generation sequencing (NGS).
    Gerratana, Lorenzo
    Davis, Andrew A.
    Velimirovic, Marko
    D'Amico, Paolo
    Shah, Ami N.
    Clifton, Katherine
    Zhang, Qiang
    Dai, Charles Sichao
    Reduzzi, Carolina
    Hensing, Whitney L.
    Bonotto, Marta
    Mazzeo, Roberta
    Wehbe, Firas Hazem
    Franzoni, Alessandra
    Belletti, Barbara
    Behdad, Amir
    Ma, Cynthia X.
    Puglisi, Fabio
    Bardia, Aditya
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Impact of next-generation sequencing vs polymerase chain reaction testing on payer costs and clinical outcomes throughout the treatment journeys of patients with metastatic non-small cell lung cancer
    Bestvina, Christine M.
    Waters, Dexter
    Morrison, Laura
    Emond, Bruno
    Lafeuille, Marie-Helene
    Hilts, Annalise
    Mujwara, Deo
    Lefebvre, Patrick
    He, Andy
    Vanderpoel, Julie
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (12): : 1467 - 1478
123